How is this helpful?
Honestly I despair at the quality of discussion when almost everyone piles into the company, suspends what they know to be the most likely LT situation for the company and slams the company as
not really caring.
How much can they control?
Not the FDA, not the market, not the shorters and short ladder attacks including what goes on in here, not opportunistic low ball partnership offers.
We have to get the FDA to reform and this is slow but traction is happening.
People are whingeing about the SP as if the company has done this deliberately, and to shut up agitating posters in HC about not making the offers to retail investors.
Hello? The reality is the company could be subject to a hostile takeover and needs shareholder support from LT not opportunistic buyers. SI has strutured the company carefully to insulate but nothing is certain and we are in this position of needing to raise capital and we need solid LT holders not traders. Not takeovers.
Do you care about the impact of your words?
- Forums
- ASX - By Stock
- MSB
- Ann: Information For Retail Shareholders
Ann: Information For Retail Shareholders, page-22
-
- There are more pages in this discussion • 520 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.16 |
Change
-0.030(2.52%) |
Mkt cap ! $1.324B |
Open | High | Low | Value | Volume |
$1.18 | $1.22 | $1.15 | $4.629M | 3.927M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
37 | 29476 | $1.16 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 106203 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
19 | 22446 | 1.160 |
27 | 44419 | 1.155 |
17 | 154046 | 1.150 |
14 | 206116 | 1.145 |
9 | 199738 | 1.140 |
Price($) | Vol. | No. |
---|---|---|
1.165 | 111996 | 12 |
1.170 | 64280 | 10 |
1.175 | 72571 | 10 |
1.180 | 74516 | 7 |
1.185 | 36343 | 4 |
Last trade - 14.37pm 15/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online